Document Detail


Nifedipine and acute myocardial infarction.
MedLine Citation:
PMID:  7227967     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In consideration of the results of experimental studies indicating that nifedipine, a vasodilating calcium antagonist with little inotropic or electrophysiological effects, increases coronary flow to both normal and ischemic zones potentially rendering protection of ischemic myocardium as well as the results of clinical studies in patients with angina pectoris, this pilot study was carried out in patients with acute myocardial infarction to evaluate the clinical, hemodynamic and electrophysiological responses. Nifedipine was administered sublingually in a dosage of 10 mg initially, after an interval of 1 to 1.5 hours and thereafter to maintain the pressure at the level prevailing after three hours. As compared with a control group, the frequency of ventricular dysrhythmia as well as the frequency of complex dysrhythmias in the 17 treated patients were similar (mean 313 vs. 325 PVCs/24 hours; and 5.9 vs. 3.6 episodes respectively in treated and controls). No patient developed evidence of second or third degree AV block. Systemic vascular resistance fell from 1661 to 1283 dyne . s . cm-5 and cardiac index increased from 3.2 to 3.59 l/min/m2 at one hour. Arterial pressure decreased from 146/93 to 131/88 mm Hg. Pulmonary artery pressure remained unchanged in five patients and decreased by more than 3 mm Hg in four. Thus, in patients with acute myocardial infarction nifedipine decreases systemic resistance and, provided preload is not substantially reduced, increases cardiac output. Neither an exacerbation of chest pain nor an increase in ventricular dysrhythmia was observed. Extensive clinical investigation will be needed to definitively characterize effects of nifedipine on infarct size, coronary flow and prognosis of patients with acute myocardial infarction.
Authors:
R Roberts; A S Jaffe; P D Henry; B E Sobel
Related Documents :
15831987 - Changes of coronary blood flow in vasospastic angina under cold stimulation by transtho...
11939917 - Myocardial ischemia induces coronary t-pa release in the pig.
22495137 - Normal values of left-ventricular mass: echocardiographic findings from the pamela study.
3288857 - Effect of edrf release from freshly harvested endothelial cells on the coronary circula...
20098037 - Evaluation of atrial electromechanical delay and left atrial mechanical functions in pa...
10966237 - Myocardial effects of repeated electrical defibrillations in the isolated fibrillating ...
Publication Detail:
Type:  Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Herz     Volume:  6     ISSN:  0340-9937     ISO Abbreviation:  Herz     Publication Date:  1981 Apr 
Date Detail:
Created Date:  1981-07-20     Completed Date:  1981-07-20     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7801231     Medline TA:  Herz     Country:  GERMANY, WEST    
Other Details:
Languages:  eng     Pagination:  90-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Adult
Animals
Coronary Circulation / drug effects
Dogs
Hemodynamics / drug effects
Humans
Male
Middle Aged
Myocardial Infarction / drug therapy*
Nifedipine / therapeutic use*
Pyridines / therapeutic use*
Rabbits
Grant Support
ID/Acronym/Agency:
HL 17646/HL/NHLBI NIH HHS; HL 21187/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Pyridines; 21829-25-4/Nifedipine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Acute myocardial infarction: place of treatment and length of stay.
Next Document:  Uptake and binding of [3H]aldosterone by the anterior pituitary and brain regions in adrenalectomize...